Pulmonary precapillary hypertension (h. pulmonalis praecapillaris) is a pathological condition characterized by a persistent increase in pressure in the pulmonary vessels located up to the capillaries.
The cause of the development of precapillary pulmonary hypertension can be various diseases of the lungs and respiratory tract, such as chronic obstructive pulmonary disease, interstitial lung diseases, sarcoidosis, tuberculosis, etc. Pulmonary thromboembolism, mediastinal tumors, and chest deformities can also be the cause.
Clinical manifestations include shortness of breath, weakness, dizziness, chest pain, swelling in the legs, and cyanosis. Diagnosis is based on anamnesis, physical examination, instrumental methods - ECG, echocardiography, chest x-ray, computed tomography.
Treatment is aimed at eliminating the causes underlying the disease. Diuretics, anticoagulants, and oxygen therapy are used. If conservative therapy is ineffective, a lung transplant may be required. The prognosis depends on the cause and severity of the course; with timely treatment it can be favorable.
Pulmonary precapillary hypertension (Hypertonia pulmonale praecapillarich) is a form of disease in which normal blood circulation in the lungs is disrupted, which increases the pressure in the vessels feeding the tissues of the organ. This form of hypertension does not occur due to increased stress on the